» Articles » PMID: 34738554

The Role of Pelvic Ultrasound for the Diagnosis and Management of Central Precocious Puberty: An Update

Overview
Journal Acta Biomed
Specialty General Medicine
Date 2021 Nov 5
PMID 34738554
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Sexual precocity refers to the appearance of physical and hormonal signs of pubertal development at an earlier age. It may be considered as the expression of secondary sexual characteristics prior to the pubertal age In central precocious puberty (CPP), which is gonadotropin-dependent, early maturation of the entire hypothalamic-pituitary-gonadal (HPG) axis occurs, with the full spectrum of physical and hormonal changes of puberty. True precocious puberty in girls must also be distinguished from premature thelarche (PT), usually with breast development before the age of 3 years, and premature pubarche (PA), with the isolated development of pubic hair. These conditions are not usually associated with accelerated growth rate or advancement in bone age. Clinical, laboratory and instrumental evaluations are necessary for the diagnosis. Pelvic ultrasound could serve as a complementary tool for the diagnosis, treatment and follow-up of CPP. The interpretation of clinical, laboratory and strumental data must be performed by an expert pediatric endocrinologist to maximize the diagnostic value in females with pubertal disorders.

Citing Articles

Magnetic resonance imaging -based radiomics of the pituitary gland is highly predictive of precocious puberty in girls: a pilot study.

Maddalo M, Petraroli M, Ormitti F, Fulgoni A, Gnocchi M, Masetti M Front Endocrinol (Lausanne). 2025; 16:1496554.

PMID: 39974824 PMC: 11835667. DOI: 10.3389/fendo.2025.1496554.


Predictive value of transabdominal pelvic ultrasonography for the diagnosis of central precocious puberty: A single-center observational retrospective study.

Sessa L, Rotunno G, Sodero G, Pane L, Rendeli C, Maresca G Clin Pediatr Endocrinol. 2024; 33(4):199-206.

PMID: 39359668 PMC: 11442698. DOI: 10.1297/cpe.2024-0025.


Development and application of a nomogram model for predicting the risk of central precocious puberty in obese girls.

Huang R, Yang L, Yang Y, Xu Q, Xie L, Cao L Front Pediatr. 2024; 12:1421775.

PMID: 39281189 PMC: 11393738. DOI: 10.3389/fped.2024.1421775.


Abdominal imaging in precocious puberty in girls: can imaging determine onset of puberty?.

Smets A, Sofia C, Bruno C, Kljucevsek D, Lobo M, Napolitano M Pediatr Radiol. 2024; .

PMID: 39069591 DOI: 10.1007/s00247-024-05992-8.


Screening for central precocious puberty by single basal Luteinizing Hormone levels.

Li Pomi A, Scalini P, De Masi S, Corica D, Pepe G, Wasniewska M Endocrine. 2024; 85(2):955-963.

PMID: 38507183 PMC: 11291536. DOI: 10.1007/s12020-024-03781-9.


References
1.
de Vries L, Phillip M . Role of pelvic ultrasound in girls with precocious puberty. Horm Res Paediatr. 2011; 75(2):148-52. DOI: 10.1159/000323361. View

2.
Yu H, Liu X, Chen J, Wang S, Quan X . Pelvic Ultrasound in Diagnosing and Evaluating the Efficacy of Gonadotropin-Releasing Hormone Agonist Therapy in Girls With Idiopathic Central Precocious Puberty. Front Pharmacol. 2019; 10:104. PMC: 6378315. DOI: 10.3389/fphar.2019.00104. View

3.
Calcaterra V, Klersy C, Vinci F, Regalbuto C, Dobbiani G, Montalbano C . Rapid progressive central precocious puberty: diagnostic and predictive value of basal sex hormone levels and pelvic ultrasound. J Pediatr Endocrinol Metab. 2020; 33(6):785-791. DOI: 10.1515/jpem-2019-0577. View

4.
Kletter G, Kelch R . Clinical review 60: Effects of gonadotropin-releasing hormone analog therapy on adult stature in precocious puberty. J Clin Endocrinol Metab. 1994; 79(2):331-4. DOI: 10.1210/jcem.79.2.8045943. View

5.
Weise M, Flor A, Barnes K, Cutler Jr G, Baron J . Determinants of growth during gonadotropin-releasing hormone analog therapy for precocious puberty. J Clin Endocrinol Metab. 2004; 89(1):103-7. DOI: 10.1210/jc.2002-021999. View